Portola Pharmaceuticals

270 E Grand Ave
South San Francisco,  CA  94080-4811

United States
  • Booth: 3079

Portola Pharmaceuticals, Inc. was founded in 2003 and is headquartered in San Francisco, California. Our goal is to build an enduring biopharmaceutical company with compounds from our own research efforts that represent significant advances in the fields of thrombosis and other hematologic diseases. Each of our therapies has the potential to address a significant unmet need. We are advancing our candidates [Betrixaban, Andexanet alfa, Cerdulatinib] using novel biomarker and genetic approaches.